Mesa Laboratories (MLAB) Earnings Analysis

Mesa Laboratories (MLAB) next reports earnings on 2026-08-10, consensus EPS 2.63 USD. Last quarter (2026-05-27) it beat with EPS 2.76 USD vs 2.09 USD est (+32.1%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 80.14.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MLAB next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate2.63 USD
Revenue estimate0.06B

MLAB earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-272.76 USD2.09 USD+32.1%Beat
2026-02-033.07 USD1.4 USD+119.3%Beat
2025-11-061.76 USD1.56 USD+12.8%Beat
2025-05-282.23 USD2.75 USD-18.9%Miss
2024-08-052.83 USD2.33 USD+21.5%Beat

Beat rate: 4/5 (80%) over reported quarters with consensus data.

MLAB valuation and analyst view

Trailing P/E80.14
Trailing EPS1.211 USD
Price / book2.93
Dividend yield0.65%
Market cap0.54B
Analyst consensusHold (3 buy / 5 hold / 0 sell)
Avg price target88.5 USD

Related research pages

Frequently asked questions

When is Mesa Laboratories (MLAB)'s next earnings date?

Mesa Laboratories is next scheduled to report on 2026-08-10, with a consensus EPS estimate of 2.63 USD and revenue estimate of 0.06B.

Did MLAB beat earnings last quarter?

In its 2026-05-27 report, MLAB posted EPS of 2.76 USD versus a 2.09 USD estimate — a beat of 32.1%.

What is MLAB's earnings track record?

Over the last 5 reported quarters with consensus data, MLAB beat estimates 4 times (80%).

What is MLAB's current P/E ratio and EPS?

MLAB trades at a trailing P/E of 80.14 on trailing EPS of 1.2106782106782106 USD.

What do analysts rate MLAB?

Analyst consensus is "Hold" across 8 ratings (0 strong buy, 3 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 88.5 USD.